Abstract
SUMMARY. Prenatal typing for the human platelet antigens‐1 (HPA) permits identification of a fetus at risk for neonatal alloimmune thrombocytopenia (NAITP) in cases of HPA‐1 incompatibility in which the father is heterozygous for the HPA‐la antigen. Diagnostic cordocentesis and phenotyping of the fetal platelets are used for this purpose. We applied allele‐specific restriction enzyme analysis on polymerase chain reaction (PCR)‐amplified DNA purified from amniocytes. This assay allows early second trimester typing for HPA‐1 alleles. We were able to determine the genotype of three fetuses at risk. Iatrogenic fetal loss is lower with amniocentesis than with cordocentesis. Therefore, this technique is a welcome addition to the antenatal management of NAITP.
| Original language | English |
|---|---|
| Pages (from-to) | 15-19 |
| Number of pages | 5 |
| Journal | Transfusion Medicine |
| Volume | 4 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Mar 1994 |
Keywords
- allele‐specific restriction enzyme analysis
- DNA polymorphism
- HPA‐1 (Zw/P1)
- neonatal alloimmune thrombocytopenia
- platelets
- prenatal diagnosis